Suppr
超能文献

Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.

作者信息

Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y

出版信息

Bone Marrow Transplant. 2009 Sep;44(5):327-9. doi: 10.1038/bmt.2009.18. Epub 2009 Feb 16.

DOI:10.1038/bmt.2009.18

PMID:19219076

Abstract

摘要

相似文献

Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.

Bone Marrow Transplant. 2009 Sep;44(5):327-9. doi: 10.1038/bmt.2009.18. Epub 2009 Feb 16.

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.

Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65. doi: 10.1016/j.bbmt.2008.11.025.

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Blood. 2002 Mar 1;99(5):1572-7. doi: 10.1182/blood.v99.5.1572.

Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.

Tissue Antigens. 2008 Dec;72(6):549-58. doi: 10.1111/j.1399-0039.2008.01148.x. Epub 2008 Oct 18.

HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):98-104. doi: 10.1016/j.bcmd.2009.02.005. Epub 2009 Apr 7.

Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan.

Bone Marrow Transplant. 2006 Nov;38(10):681-6. doi: 10.1038/sj.bmt.1705506. Epub 2006 Sep 18.

The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT.

Bone Marrow Transplant. 2009 Jan;43(1):29-36. doi: 10.1038/bmt.2008.267. Epub 2008 Sep 8.

[Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors].

Gan To Kagaku Ryoho. 2009 Nov;36(11):1845-9.

A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.

Biol Blood Marrow Transplant. 2009 Aug;15(8):930-7. doi: 10.1016/j.bbmt.2009.04.006.

Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.

Blood. 2004 Dec 1;104(12):3821-8. doi: 10.1182/blood-2004-03-1212. Epub 2004 Jul 27.

引用本文的文献

Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism.

Clin Chem. 2021 Jan 30;67(2):351-362. doi: 10.1093/clinchem/hvaa304.

Lower incidence of acute GVHD is associated with the rapid recovery of CD4CD25CD45RA regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study.

Oncoimmunology. 2016 Oct 14;5(12):e1242546. doi: 10.1080/2162402X.2016.1242546. eCollection 2016.

[How I choose the best donor in allogeneic hematopoietic stem cell transplantation settings].

Zhonghua Xue Ye Xue Za Zhi. 2016 Aug 14;37(8):643-9. doi: 10.3760/cma.j.issn.0253-2727.2016.08.003.

How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

J Hematol Oncol. 2016 Apr 12;9:35. doi: 10.1186/s13045-016-0265-2.

Tolerance to noninherited maternal antigens, reproductive microchimerism and regulatory T cell memory: 60 years after 'Evidence for actively acquired tolerance to Rh antigens'.

Chimerism. 2015 Apr 3;6(1-2):8-20. doi: 10.1080/19381956.2015.1107253. Epub 2015 Oct 30.

A feasibility study on the prediction of acute graft-vs.-host disease before hematopoietic stem cell transplantation based on fetomaternal tolerance.

Chimerism. 2013 Jul-Sep;4(3):84-6. doi: 10.4161/chim.24718. Epub 2013 Sep 12.

Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation.

Front Immunol. 2012 May 25;3:135. doi: 10.3389/fimmu.2012.00135. eCollection 2012.

Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Chimerism. 2011 Jan;2(1):23-4. doi: 10.4161/chim.2.1.15127.

Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation.

Chimerism. 2010 Jul-Sep;1(1):39-43. doi: 10.4161/chim.1.1.12743.

Haploidentical transplantation for leukemia.

Curr Oncol Rep. 2010 Sep;12(5):292-301. doi: 10.1007/s11912-010-0113-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译